|
1
|
Riaz SK, Saeed M and Malik MF: Clinical
and therapeutic implications of histone acetylation in breast
cancer. West Indian Med J. May 6–2015.(Epub ahead of print).
View Article : Google Scholar
|
|
2
|
Strasser-Weippl K, Horick N, Smith IE,
O'Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P,
Gradishar W, Martin M, et al: Identification of early breast cancer
patient cohorts who may benefit from lapatinib therapy. Eur J
Cancer. 56:85–92. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sage EK, Schmid TE, Sedelmayr M, Gehrmann
M, Geinitz H, Duma MN, Combs SE and Multhoff G: Comparative
analysis of the effects of radiotherapy versus radiotherapy after
adjuvant chemotherapy on the composition of lymphocyte
subpopulations in breast cancer patients. Radiother Oncol.
118:176–180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Smoot B, Paul SM, Aouizerat BE, Dunn L,
Elboim C, Schmidt B, Hamolsky D, Levine JD, Abrams G, Mastick J, et
al: Predictors of altered upper extremity function during the first
year after breast cancer treatment. Am J Phys Med Rehabil.
95:639–655. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Partridge AH: Chemotherapy in
premenopausal breast cancer patients. Breast Care (Basel).
10:307–310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu YY, Si W, Ji TF, Guo XQ, Hu Y and Yang
JL: The variation and clinical significance of hormone receptors
and Her-2 status from primary to metastatic lesions in breast
cancer patients. Tumour Biol. 37:7675–7684. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin PL, Hao Y, Xie J, Li N, Zhong Y, Zhou
Z, Signorovitch JE and Wu EQ: Physician experiences and preferences
in the treatment of HR+/HER2- metastatic breast cancer in the
United States: A physician survey. Cancer Med. 5:209–220. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rossi L and Pagani O: The modern landscape
of endocrine therapy for premenopausal women with breast cancer.
Breast Care (Basel). 10:312–315. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hosono K, Yamada E, Endo H, Takahashi H,
Inamori M, Hippo Y, Nakagama H and Nakajima A: Increased tumor
necrosis factor receptor 1 expression in human colorectal adenomas.
World J Gastroenterol. 18:5360–5368. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ,
Liu GY, Syed NM, Lai Y, Lin EA, Kong L, et al: The growth factor
progranulin binds to TNF receptors and is therapeutic against
inflammatory arthritis in mice. Science. 332:478–484. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo Z, Li Q, Han Y, Liang Y, Xu Z and Ren
T: Prevention of LPS-induced acute lung injury in mice by
progranulin. Mediators Inflamm. 2012:5407942012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao YP, Tian Q, Frenkel S and Liu CJ: The
promotion of bone healing by progranulin, a downstream molecule of
BMP-2, through interacting with TNF/TNFR signaling. Biomaterials.
34:6412–6421. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arnott CH, Scott KA, Moore RJ, Robinson
SC, Thompson RG and Balkwill FR: Expression of both TNF-alpha
receptor subtypes is essential for optimal skin tumour development.
Oncogene. 23:1902–1910. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tanimura Y, Kokuryo T, Tsunoda N, Yamazaki
Y, Oda K, Nimura Y, Mon N Naing, Huang P, Nakanuma Y, Chen MF, et
al: Tumor necrosis factor alpha promotes invasiveness of
cholangiocarcinoma cells via its receptor, TNFR2. Cancer Lett.
219:205–213. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jöhrer K, Janke K, Krugmann J, Fiegl M and
Greil R: Transendothelial migration of myeloma cells is increased
by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and
autocrine up-regulation of MCP-1. Clin Cancer Res. 10:1901–1910.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Grotowski M and Wojtuń S: CEA, CA-19-9 and
il-8, sTNFRII and sil-2R in persons at high risk of colorectal
cancer. Pol Merkur Lekarski. 14:327–330. 2003.(In Polish).
PubMed/NCBI
|
|
17
|
Heemann C, Kreuz M, Stoller I, Schoof N,
von Bonin F, Ziepert M, Löffler M, Jung W, Pfreundschuh M, Trümper
L and Kube D: Circulating levels of TNF receptor II are prognostic
for patients with peripheral T-cell non-Hodgkin lymphoma. Clin
Cancer Res. 18:3637–3647. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jablonska E: Release of soluble IL-6
receptor (IL-6sR) in comparison with release of soluble TNF
receptors (sTNF-Rs) by PMNs and WBC derived from breast cancer
patients. Cancer Lett. 119:79–85. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tesarová P, Kvasnicka J, Umlaufová A,
Homolková H, Jirsa M and Tesar V: Soluble TNF and IL-2 receptors in
patients with breast cancer. Med Sci Monit. 6:661–667.
2000.PubMed/NCBI
|
|
20
|
Xu F, Zhou G, Han S, Yuan W, Chen S, Fu Z,
Li D, Zhang H, Li D and Pang D: Association of TNF-α, TNFRSF1A and
TNFRSF1B gene polymorphisms with the risk of sporadic breast cancer
in northeast Chinese Han women. PLoS One. 9:e1011382014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mizoguchi E, Mizoguchi A, Takedatsu H,
Cario E, de Jong YP, Ooi CJ, Xavier RJ, Terhorst C, Podolsky DK and
Bhan AK: Role of tumor necrosis factor receptor 2 (TNFR2) in
colonic epithelial hyperplasia and chronic intestinal inflammation
in mice. Gastroenterology. 122:134–144. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mestiri S, Bouaouina N, Ben Ahmed S and
Chouchane L: A functional polymorphism of the tumor necrosis factor
receptor-II gene associated with the survival and relapse
prediction of breast carcinoma. Cytokine. 30:182–187. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
García-Tuñón I, Ricote M, Ruiz A, Fraile
B, Paniagua R and Royuela M: Role of tumor necrosis factor-alpha
and its receptors in human benign breast lesions and tumors (in
situ and infiltrative). Cancer Sci. 97:1044–1049. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang D, Wang LL, Dong TT, Shen YH, Guo XS,
Liu CY, Liu J, Zhang P, Li J and Sun YP: Progranulin promotes
colorectal cancer proliferation and angiogenesis through TNFR2/Akt
and ERK signaling pathways. Am J Cancer Res. 5:3085–3097.
2015.PubMed/NCBI
|
|
25
|
Mouttet D, Laé M, Caly M, Gentien D,
Carpentier S, Peyro-Saint-Paul H, Vincent-Salomon A, Rouzier R,
Sigal-Zafrani B, Sastre-Garau X and Reyal F: Estrogen-receptor,
progesterone-receptor and HER2 status determination in invasive
breast cancer. Concordance between immuno-histochemistry and
MapQuant microarray based assay. PLoS One. 11:e01464742016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pizot C, Boniol M, Mullie P, Koechlin A,
Boniol M, Boyle P and Autier P: Physical activity, hormone
replacement therapy and breast cancer risk: A meta-analysis of
prospective studies. Eur J Cancer. 52:138–154. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chai P, Tian J, Zhao D, Zhang H, Cui J,
Ding K and Liu B: GSE1 negative regulation by miR-489-5p promotes
breast cancer cell proliferation and invasion. Biochem Biophys Res
Commun. 471:123–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Richards P, Ward S, Morgan J, Lagord C,
Reed M, Collins K and Wyld L: The use of surgery in the treatment
of ER+ early stage breast cancer in England: Variation by time, age
and patient characteristics. Eur J Surg Oncol. 42:489–496. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qiu J, Xue X, Hu C, Xu H, Kou D, Li R and
Li M: Comparison of clinicopathological features and prognosis in
triple-negative and non-triple negative breast cancer. J Cancer.
7:167–173. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ingthorsson S, Andersen K, Hilmarsdottir
B, Maelandsmo GM, Magnusson MK and Gudjonsson T: HER2 induced EMT
and tumorigenicity in breast epithelial progenitor cells is
inhibited by coexpression of EGFR. Oncogene. 35:4244–4255. 2016.
View Article : Google Scholar : PubMed/NCBI
|
